The first MASH drug therapy on the horizon: Current perspectives of resmetirom

Petta, S., Targher, G., Romeo, S., Pajvani, U. B., Zheng, M., Aghemo, A., & Valenti, L. V. C. (2024). The first MASH drug therapy on the horizon: Current perspectives of resmetirom. Liver International, 44(7), 1526–1536. Portico. https://doi.org/10.1111/liv.15930
Authors:
Salvatore Petta
Giovanni Targher
Stefano Romeo
Utpal B. Pajvani
Ming‐Hua Zheng
Alessio Aghemo
Luca Valenti
Affiliated Authors:
Utpal B. Pajvani
Columbia Affiliation:
Subjects:
Fatty Liver (MeSH)
Epidemiology and Management of NAFLD (OpenAlex Topic)
Diagnosis and Management of Liver Diseases (OpenAlex Topic)
Liver Cirrhosis and Associated Complications (OpenAlex Topic)
elink
Publication Type:
Article
Unique ID:
10.1111/liv.15930
PMID:
38578141
DOI:
10.1111/liv.15930
Journal:
Liver International
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record
View PubMed Record

Record Created: